Not applicableUnknownNCT02471885What this trial is testingEffect of Remote Ischaemic Conditioning in Oncology PatientsWho this might be right forCardiotoxicity University College, London 128
Post-approval studies (Phase 4)WithdrawnNCT03392740What this trial is testingProphylactic Lisinopril to Prevent Anthracycline Cardiomyopathy.Who this might be right forCardiomyopathy Due to DrugHeart Failure, Systolic Ascension Health
Not applicableUnknownNCT03155802What this trial is testingNovel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving AnthracyclinesWho this might be right forCardiotoxicityHeart FailureBreast Cancer+3 more Stony Brook University 35
Post-approval studies (Phase 4)Study completedNCT02053974What this trial is testingSpironolactone Against Anthracycline-induced CardiomyopathyWho this might be right forAnthracycline Induced Cardiotoxicity TC Erciyes University 90
Large-scale testing (Phase 3)UnknownNCT05792293What this trial is testingRole of Statin Therapy in Prevention of Anthracycline-Induced CardiotoxicityWho this might be right forDoxorubicin Induced Cardiomyopathy Ain Shams University 100
Not applicableStudy completedNCT05731375What this trial is testingMitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE DamageWho this might be right forDoxorubicin Induced CardiomyopathyChemotherapeutic ToxicityAnthracyclines UMC Utrecht 12
Not applicableEnded earlyNCT05781672What this trial is testingPrediction of Delayed Toxic Cardiomyopathy in ChildrenWho this might be right forCardiotoxicityChildhood Cancer University Hospital, Montpellier 134
Not applicableUnknownNCT04461223What this trial is testingEvaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMRWho this might be right forCardiotoxicityOsteosarcomaMyocardial Injury+2 more Second Affiliated Hospital, School of Medicine, Zhejiang University 55
Large-scale testing (Phase 3)Looking for participantsNCT06711185What this trial is testingEffect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based ChemotherapyWho this might be right forBreast Cancer University of Campinas, Brazil 80
Testing effectiveness (Phase 2)Study completedNCT04737265What this trial is testingPilot Study of an NTproBNP Guided Strategy of CardioprotectionWho this might be right forCardiotoxicityToxicity Due to ChemotherapyBreast Cancer+3 more Abramson Cancer Center at Penn Medicine 101
Early research (Phase 1)Study completedNCT02509156What this trial is testingStem Cell Injection in Cancer SurvivorsWho this might be right forCardiomyopathy Due to Anthracyclines The University of Texas Health Science Center, Houston 46
Not applicableUnknownNCT06331806What this trial is testingMyocardial Fibrosis Identification in Patients With Anthracycline-induced CardiotoxicityWho this might be right forCardiomyopathy Due to Drug European Institute of Oncology 100
Not applicableUnknownNCT04852965What this trial is testingLate Anthracycline Induced Cardiotoxicity- Childhood Cancer SurvivorsWho this might be right forAnthracycline Induced Cardiotoxicity Queen's University, Belfast 103
Post-approval studies (Phase 4)Not Yet RecruitingNCT07254221What this trial is testingRosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer PatientsWho this might be right forAnthracycline-induced Cardiac ToxicityBreast CancerAnthracycline Related Cardiotoxicity in Breast Cancer+1 more Shiraz University of Medical Sciences 400
Post-approval studies (Phase 4)Ended earlyNCT00806390What this trial is testingPrevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by MetoprololWho this might be right forCardiomyopathy University of Maryland, Baltimore 15
Not applicableStudy completedNCT03166813What this trial is testingRemote Ischaemic Preconditioning in Childhood CancerWho this might be right forCardiotoxicity The University of Hong Kong 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07370506What this trial is testingTelmisartan for Prevention of Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsWho this might be right forBreast CancerDoxorubicin Induced Cardiomyopathy Tanta University 36
Large-scale testing (Phase 3)Study completedNCT05175066What this trial is testingBisoprolol Administration to Prevent Anthracycline-induced CardiotoxicityWho this might be right forCardiomyopathiesChemotherapy EffectDiastolic Dysfunction+1 more Shahid Beheshti University of Medical Sciences 80